The platinum biological innovation platform project undertaken by the group company was successfully started
Release time:
2022-03-04
The platinum biological innovation platform project undertaken by the group company was successfully started
On March 3, the phase I project of platinum biological stem cell therapy innovation platform and industrial base undertaken by the group company was inaugurated in Beijing Yizhuang cell therapy pilot base. Lu Weihong, vice president of the group company and head of Beijing company, attended the event. Bosheng Zhuoyue Biotechnology Co., Ltd. is a high-tech company committed to the research and development of new stem cell drugs. It has the foundation of the world's leading basic research and clinical transformation achievements of stem cells. The industrial base project under construction is a comprehensive international stem cell industrialization platform integrating R & D, pilot test, production and technical services. The 121 fan Jiarong Project Department of Jinrun branch is responsible for the construction. Lu Weihong said that Jiangsu Qi'an will give full play to its professional and technical advantages, adhere to civilized and green construction, build high-quality buildings with "craftsman spirit", ensure the completion of the project on schedule and hand over a satisfactory answer to the owner. (Beijing company)

Recommended news
2026-10-08
In late September, the China Construction Enterprise Management Association organized an experience-sharing and on-site observation conference on quality and safety management in construction projects in Guangzhou, which was attended by representatives from the Group.
2026-09-21
Empowering Communities Through Health: Experts Bring Science-Based Education to Qian’an
On September 18, Jiangsu Qian’an Construction Group, in collaboration with the Science Education Base of Qidong People’s Hospital, hosted the 2026 National Science Popularization Event.
2026-09-18
In mid-September, a foreign‑owned expert audit team from Jotun’s Norwegian headquarters conducted a three‑day, headquarter‑level specialized safety audit on the Jotun Zhangjiagang project site undertaken by the Group.
2026-09-18
The Roche (Shanghai) project of the Group has successfully achieved 2 million safe man-hours.
On September 17, the Roche (Shanghai) Biopharmaceutical Production Base project, undertaken by the Group, successfully reached the milestone of 2 million safe man-hours.
2026-09-18
On September 16–17, the China Chemical Construction Enterprises Association held a training course on building “Quality‑Trusted Work Teams” in Chengdu, with representatives from the Group in attendance. The session featured a live lecture by Shi Jie, a senior expert of the Association.
2026-09-09
Good News Abounds | The Group Has Secured Multiple Emerging Industry Projects in Succession
In the golden autumn season, bountiful harvests abound, and new‑generation growth sectors showcase their strength. Since August, leveraging its deep-rooted expertise and core competencies in industrial installation, the Group has successively won bids for five key projects in emerging productivity fields, with a total contract value exceeding RMB 250 million, injecting robust momentum into its resilient year‑end performance.